Gennery, Dr Andrew

Dr Andrew GenneryHonorary Consultant in Paediatric Immunology and Haematopoietic Stem Cell Transplantation

  • Honorary Consultant in Paediatric Immunology and Haematopoietic Stem Cell Transplantation
  • Tel: 0191 282 5234
  • GMC Code: 3357592
  • Qualifications: MBChB, MD
  • Special Interests

    Paediatric Immunology and Haematopoietic Stem Cell Transplantation.

  • Biography

    Andrew Gennery spent a year of post-doctoral studies working with Anne Durandy and Alain Fischer in the Necker Hospital in Paris and was involved in the discovery of Cytidine Deaminase one of the first genes to be discovered involved in class switch recombination and somatic hypermutation.

    His research interests include immunoreconstitution following haematopoietic stem cell transplant for primary immunodeficiency, long-term outcomes of transplantation for primary immunodeficiency DNA repair disorders and their appropriate treatment. He has adapted new methods of T-cell depletion for patients with primary immunodeficiency, and established extracorporeal photopheresis for the treatment of children with graft versus host disease.

    He is a member of ESID and EBMT and currently chairs the ESID/EBMT Inborn Errors Working Party group. He has written international guidelines for the treatment of patients with DNA repair disorders and CD40 ligand deficiency. He is currently part of the working group writing guidelines for the use of extracorporeal photopheresis for the treatment of acute graft versus host disease.

    He is currently Programme Director for the Academic Foundation Programme in the Northern Deanery. He is the Human Tissue Authority Designated Individual overseeing tissue for therapeutic use within Newcastle.

  • Directorate

    Children's Services

  • Hospital Base

    Great North Children's Hospital

  • Andrew Gennery 
© Copyright Newcastle upon Tyne Hospitals NHS Foundation Trust 2017 Site by TH_NK